2007
DOI: 10.1177/1054773806295240
|View full text |Cite
|
Sign up to set email alerts
|

Medication Use and Symptoms in Individuals With Mitral Valve Prolapse Syndrome

Abstract: Mitral valve prolapse (MVP) is a common valvular heart disease associated with a variety of frightening symptoms. Beta-adrenergic blockers along with calcium channel blockers and anxiolytics are widely used to treat symptoms associated with MVPS despite a lack of evidence that supports their efficacy. This study examined the relationship between prescribed medication use and frequency and intensity of MVPS symptoms. A descriptive cross-sectional survey design was used. Descriptive statistics and Cramér's V cor… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2012
2012
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(2 citation statements)
references
References 17 publications
0
2
0
Order By: Relevance
“…There is no effective pharmacological treatment inhibiting the progression of MVP to MR or preventing the occurrence of adverse events (AEs), including malign arrhythmias or SCD. Although MVP, even when complicated by moderate or even severe mitral regurgitation, usually remains asymptomatic in its early stage, atrial and ventricular remodeling including fibrosis occur [82].…”
Section: Early Surgery For Mvp May Provide a Treatment Option For At-...mentioning
confidence: 99%
“…There is no effective pharmacological treatment inhibiting the progression of MVP to MR or preventing the occurrence of adverse events (AEs), including malign arrhythmias or SCD. Although MVP, even when complicated by moderate or even severe mitral regurgitation, usually remains asymptomatic in its early stage, atrial and ventricular remodeling including fibrosis occur [82].…”
Section: Early Surgery For Mvp May Provide a Treatment Option For At-...mentioning
confidence: 99%
“…These considerations justify the high social importance attached to MVP. Other relevant facts include the following: a pronounced dissociation between numerous subjective complaints of the patients, on the one hand, and the scanty data from objective studies, on the other (Joiner & Cornman, 1986;Montvila & Sargautite, 1983); indications of widespread anxiety disorders accompanying MVP and the unpleasant inclusion of the formation of "functional MVP" within panic disorder (some authors assert that panic attacks not only may be "triggered" by MVP but may lead to its development: Coplan, Papp, King, & Gorman, 1992;Gorman et al, 1988); cases of a genuine reduction in the intensity of clinical symptoms after psychotherapy and antidepressant or anxiolytic treatment (Gonzalez et al, 2002;Pariser, Reynolds, Falko, Jones, & Mencer, 1981;Scordo, 2007;Stavrakaki, Williams, Boisjoli, Vlad, & Chassé, 1991); there is even some evidence that such treatment may be symptomatolytic-that is, it may result in the complete disappearance of echocardiographic MVP indicators in patients suffering from panic disorders (Coplan et al, 1992).…”
mentioning
confidence: 99%